Ophthalmic Genetics and Gene Therapy


Gene therapy is a fast-paced method that controls genetic expression to treat disease. Often, through genetic therapy, genes are implanted in cells to reproduce protein production that may have been impaired due to a patient's DNA. These genes are usually presented with a vector designed to deliver genes to patients' cells. Ophthalmic genetics is a branch of ophthalmology that specializes in the field of research. Leber Congenital Amaurosis (LCA) is a genetic disorder that causes defects by birth in children. Scientists and doctors have treated the disease with the help of genetic engineering.



Genetics of Myopia Development



Gene Therapy



Usher syndrome



Familial exudative vitreous retinopathy



Retinoblastoma



Leber hereditary optic neuropathy (LHON)



Optic atrophy



Genetics of Myopia Development



 


  • Genetics of Myopia Development
  • Gene Therapy
  • Usher syndrome
  • Familial exudative vitreous retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy
  • Genetics of Myopia Development

Related Conference of Ophthalmic Genetics and Gene Therapy

September 16-17, 2025

20th International Conference on Ophthalmology and Vision Science

Amsterdam, Netherlands
September 22-23, 2025

8th International Eye and Vision Congress

Amsterdam, Netherlands
October 20-21, 2025

6th World Congress on Ophthalmology and Vision Science

Barcelona, Spain
November 03-04, 2025

39th European Ophthalmology Congress

Rome, Italy
January 12-13, 2026

26th Global Ophthalmologists Annual Meeting

London, UK
April 20-21, 2026

3rd International Conference on Ophthalmology

Barcelona, Spain
May 07-08, 2026

7th International Conference on Optometry

Paris, France
May 25-26, 2026

10th World Congress on Eye and Vision

Madrid, Spain

Ophthalmic Genetics and Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in